C WorldWide Group’s Agios Pharmaceuticals AGIO Stock Holding History

C WorldWide Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,531	Closed	-$163K	–	115
2018 Q4	$163K	Sell	3,531 -91	-3%	-$5.62K	﹤0.01%	119
2018 Q3	$279K	Buy	3,622 +520	+17%	+$41.8K	﹤0.01%	123
2018 Q2	$261K	Hold	3,102	–	–	﹤0.01%	120
2018 Q1	$254K	Sell	3,102 -98	-3%	-$7.58K	﹤0.01%	116
2017 Q4	$183K	Sell	3,200 -600	-16%	-$37.8K	﹤0.01%	119
2017 Q3	$254K	Buy	3,800 +2,200	+138%	+$132K	﹤0.01%	120
2017 Q2	$82K	Sell	1,600 -200	-11%	-$10.2K	﹤0.01%	128
2017 Q1	$105K	Buy	+1,800	New	+$86.3K	﹤0.01%	128

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

C WorldWide Group's AGIO Position: Q1 2019 in Review

C WorldWide Group sold out of Agios Pharmaceuticals (AGIO) in Q1 2019, closing a stake of 3,531 shares — an estimated $163K sold.

C WorldWide Group first reported a position in AGIO in Q1 2017 and held it in 8 quarters. The position peaked at $279K in Q3 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

C WorldWide Group reported no remaining Agios Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
C WorldWide Group sold 3,531 Agios Pharmaceuticals shares in Q1 2019, an estimated $163K.
C WorldWide Group first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 8 quarters.
C WorldWide Group's Agios Pharmaceuticals position peaked at $279K in Q3 2018.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on C WorldWide Group's 13F filing for Q1 2019, filed 3 May 2019.